Understanding THC and CBD Ratios in UK Medical Cannabis Products

Understanding THC and CBD Ratios in UK Medical Cannabis Products

When a UK doctor prescribes medical cannabis, one of the key decisions is the THC to CBD ratio. Understanding these ratios helps patients make sense of their prescription and manage expectations about effects.

THC (tetrahydrocannabinol) is the psychoactive component. It provides pain relief, reduces nausea, stimulates appetite, and helps with sleep. Higher THC ratios are more commonly prescribed for pain management and insomnia. CBD (cannabidiol) is non-psychoactive and has anti-inflammatory, anti-anxiety, and anti-seizure properties.

Common prescriptions include CBD-dominant products with minimal THC for daytime use, balanced 1:1 THC to CBD ratios for moderate symptom management, and THC-dominant products for evening use or severe pain. The exact formulation is tailored by the prescribing doctor to each patient's condition and tolerance.

At Releaf (releaf.co.uk), the UK's largest medical cannabis provider, their 50-plus specialist doctors prescribe across the full spectrum of available products. With over 181,000 prescriptions shipped and a 4.7 Trustpilot score from nearly 7,000 reviews, they have extensive experience matching patients to optimal ratios.

The initial consultation at Releaf costs 99 pounds and includes a thorough discussion of which products and ratios are most appropriate. Follow-up appointments allow for adjustment as the patient learns how different ratios affect their symptoms. This iterative approach is standard across reputable clinics.

Products come in several forms: oils and tinctures for precise dosing, dried flower for vaporisation with faster onset, and capsules for convenience. Each delivery method interacts differently with the body, affecting both onset time and duration of relief.

For patients new to medical cannabis, starting with lower THC ratios and gradually adjusting is typical best practice. Releaf's doctors guide this titration process through scheduled follow-ups, ensuring patients find their optimal treatment without unnecessary trial and error.